Aldeyra The (ALDX) Financials

ALDX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 47.5 million 9.7 million
March 31, 2026 66.5 million 24.3 million
Dec. 31, 2025 72.1 million 27.8 million
Sept. 30, 2025 77.8 million 28.6 million

ALDX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -9.7 billion 655.4 million
March 31, 2026 -5.1 million -987554
Dec. 31, 2025 -5.3 million 1.1 million
Sept. 30, 2025 -7.0 million 2.6 million

ALDX Net Income

No data available :(

ALDX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 45.1 million - 143447
March 31, 2026 65.0 million - 212769
Dec. 31, 2025 70.0 million - 280537
Sept. 30, 2025 75.3 million - 344484

ALDX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 60.3 million
March 31, 2026 60.3 million
Dec. 31, 2025 60.2 million
Sept. 30, 2025 60.1 million

ALDX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 23.1 million 3.5 million 2.4 million -
March 31, 2026 1 2.4 million 1.1 trillion -
Dec. 31, 2025 - 4.3 million 2.4 million -
Sept. 30, 2025 4 5.4 million 2.6 million -

ALDX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 66599
Dec. 31, 2025 - 65115
Sept. 30, 2025 - 63683

ALDX

Price: $0.96

52 week price:
0.86
5.93

Earnings Per Share: -0.38 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 79624

Ebitda: -4.9 million

Market Capitalization: 55.2 million

Links: